In both cases, there was a highly significant linear growth: R 2 = 0.963 for weak opioids and R 2 = 0.991 for strong opioids.
← all excerpts
Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.
1
—
—